This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Roland Knoblauch: Innovator in Cancer Treatment
Introduction
Roland Knoblauch is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of cancer treatment, particularly focusing on genetic mutations that affect patient outcomes. His work is vital in advancing medical science and improving therapeutic strategies.
Latest Patents
Roland Knoblauch holds a patent for the "Treatment of patients having c-met exon 14 skipping mutations." This invention addresses the treatment of subjects diagnosed with cancer that is positive for c-Met exon 14 skipping mutations. His innovative approach aims to enhance the effectiveness of cancer therapies for affected patients.
Career Highlights
Knoblauch is currently associated with Janssen Biotech, Inc., where he continues to develop groundbreaking treatments. His expertise in the field has positioned him as a key player in the ongoing fight against cancer. With a focus on precision medicine, he strives to create targeted therapies that can significantly improve patient outcomes.
Collaborations
He collaborates with esteemed colleagues such as Sylvie Laquerre and Sheri Moores. Their combined efforts contribute to the advancement of cancer research and treatment methodologies.
Conclusion
Roland Knoblauch's work exemplifies the impact of innovation in the medical field. His dedication to improving cancer treatment through targeted therapies is commendable. His contributions are paving the way for future advancements in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile